Hanife Karakaya
Hanife Karakaya has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Acarer
Department of Neurology, Ege University Faculty of Medicine, Izmir, Türkiye
1 shared publication - Ahmet Özkurt
Department of Electrical and Electronics Engineering, Dokuz Eylül University, İzmir 35330, Türkiye
1 shared publication - Merve Yilmaz
Department of Nutrition and Dietetics, Faculty of Health Sciences, Izmir Tinaztepe University, Türkiye
1 shared publication - Zafer Çolakoğlu
Department of Neurology, Ege University Faculty of Medicine, Izmir, Türkiye
1 shared publication
Latest Publications
- 21 January 2026
- Published by Academician Publishing
- p. 629-652
Gebelik ve Emzirme Döneminde Baş Ağrısı Yönetimi
Gebelik ve laktasyon dönemlerinde, hormonal ve dolaşım fizyolojisindeki özgün değişimler nedeniyle baş ağrısı semptomlarının değerlendirilmesi, ayırıcı tanısının yapılması ve farmakolojik yönetimi kritik öneme sahiptir. Bu dönemdeki baş ağrıları sıklıkla primer tipte (migren, gerilim tipi) olsa da; "kırmızı bayrak" belirtilerinin (ani başlangıçlı gök gürültüsü tarzı ağrı, fokal nörolojik defisit) varlığında sekonder nedenler (preeklampsi/eklampsi, Serebral Venöz Tromboz, PRES, RCVS) titizlikle araştırılmalıdır. Gebeliğin ikinci ve üçüncü trimesterlerinde östrojenin stabilizasyonuyla migren atakları azalma eğilimi gösterirken , postpartum dönemde hormonal dalgalanma , yeni doğana bakım verme stresi ve uyku eksikliği gibi nedenlerle migren atak sıklığı artabilmektedir.Tedavide, özellikle organogenez dönemi olan ilk trimesterde non-farmakolojik yaklaşımlar (düzenli uyku, gevşeme teknikleri, yoga) öncelikle düşünülmelidir. Akut atakta ilk basamak ajan, FDA B kategorisinde yer alan ve süte geçiş oranı düşük olan asetaminofendir. Non-steroid anti-inflamatuar ilaçlar (NSAİİ), fetüste duktus arteriozusun erken kapanması riakini arttırdığı için üçüncü trimesterde kontrendike kabul edilir. Şiddetli ve asetaminofene yanıtsız migren atakları için sumatriptan, görece güvenli bir seçenek olarak değerlendirilmektedir. Profilaktik tedavide ise düşük doz propranolol veya düşük doz amitriptilin önerilmektedir; valproik asit ve topiramat gibi yüksek teratojenik potansiyele sahip antiepileptiklerden kaçınılması gerekmektedir. Gebelik ve emzirme döneminde baş ağrısı yönetimi, bireyselleştirilmiş, dikkatli ve multidisipliner bir yaklaşımla ele alınmalıdır.
- 21 January 2026
- Published by Academician Publishing
- p. 629-652
Gebelik ve Emzirme Döneminde Baş Ağrısı Yönetimi
Gebelik ve laktasyon dönemlerinde, hormonal ve dolaşım fizyolojisindeki özgün değişimler nedeniyle baş ağrısı semptomlarının değerlendirilmesi, ayırıcı tanısının yapılması ve farmakolojik yönetimi kritik öneme sahiptir. Bu dönemdeki baş ağrıları sıklıkla primer tipte (migren, gerilim tipi) olsa da; "kırmızı bayrak" belirtilerinin (ani başlangıçlı gök gürültüsü tarzı ağrı, fokal nörolojik defisit) varlığında sekonder nedenler (preeklampsi/eklampsi, Serebral Venöz Tromboz, PRES, RCVS) titizlikle araştırılmalıdır. Gebeliğin ikinci ve üçüncü trimesterlerinde östrojenin stabilizasyonuyla migren atakları azalma eğilimi gösterirken , postpartum dönemde hormonal dalgalanma , yeni doğana bakım verme stresi ve uyku eksikliği gibi nedenlerle migren atak sıklığı artabilmektedir.Tedavide, özellikle organogenez dönemi olan ilk trimesterde non-farmakolojik yaklaşımlar (düzenli uyku, gevşeme teknikleri, yoga) öncelikle düşünülmelidir. Akut atakta ilk basamak ajan, FDA B kategorisinde yer alan ve süte geçiş oranı düşük olan asetaminofendir. Non-steroid anti-inflamatuar ilaçlar (NSAİİ), fetüste duktus arteriozusun erken kapanması riakini arttırdığı için üçüncü trimesterde kontrendike kabul edilir. Şiddetli ve asetaminofene yanıtsız migren atakları için sumatriptan, görece güvenli bir seçenek olarak değerlendirilmektedir. Profilaktik tedavide ise düşük doz propranolol veya düşük doz amitriptilin önerilmektedir; valproik asit ve topiramat gibi yüksek teratojenik potansiyele sahip antiepileptiklerden kaçınılması gerekmektedir. Gebelik ve emzirme döneminde baş ağrısı yönetimi, bireyselleştirilmiş, dikkatli ve multidisipliner bir yaklaşımla ele alınmalıdır.
- Open Access
- 27 June 2025
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 10 (2) , 53-59
The relationship between Controlling Nutritional Status (CONUT) Score and Mortality in Elderly Dementia Patients Followed up in the Neurology Outpatient Clinic
Introduction: Dementia is a health issue that has become increasingly prevalent worldwide due to the rising life expectancy. It leads to dependency and eventually death. Patients over the age of 65 with dementia are at increased risk of malnutrition due to various problems with food intake. Maintaining adequate nutritional intake and nutritional status during the disease is crucial. It has been noted that loss of muscle mass, accompanied by loss of body weight and functional decline, is associated with an increased risk of morbidity and mortality in dementia patients. Guidelines emphasize that nutritional interventions should be an integral part of dementia treatment. However, the increase in dependency situations in the later stages of dementia makes it difficult to measure weight and calculate the weight change. Although different scales and indexes can be used to assess nutritional status, there is no gold standard. It has been shown that Controlling Nutritional Status (CONUT) scoring, which is created by scoring serum albumin, total cholesterol, and total lymphocytes, can be used in the early diagnosis and follow-up of malnutrition in different patient groups. Therefore, this study aims to evaluate the correlation between the CONUT score and the Mini Nutritional Assessment-Short Form (MNA-SF) in determining the malnutrition status of dementia patients aged 65 and over who are followed up in a neurology outpatient clinic and to examine the relationship between the CONUT score and mortality. Method: In the neurology outpatient clinic of a municipal day hospital, 113 patients aged 65 and over, out of 187 patients with a dementia diagnosis of at least one year, whose retrospective data were accessible, were included in the study. Their weight, height measurements, MNA-SF scores, serum albumin, total lymphocyte, and total cholesterol values were recorded from the system. The CONUT score was calculated based on biochemical data, and their three-month mortality statuses were checked from the e-Nabız system. Results: The average age of the patients was 80.9 (±7.48) years, with 63.7% being female. Most of the patients had Alzheimer's type dementia (76.9%), and 53.9% had a body mass index (BMI) of 5% in the last three months, while a negative correlation was found with BMI. Although there was no difference in the number of hospital admissions, those with malnutrition had a higher need for hospital admission (p=0.029). The mortality status of patients, regardless of age and years with dementia, was statistically significant with a CONUT score of ≥2 (0.63 (95% CI: 0.57-0.73)). Conclusion: A negative correlation was shown between the CONUT score (≥2 points), calculated with biochemical markers, and the MNA-SF, which is recommended for frequent use in the elderly for determining malnutrition. The CONUT score's association with BMI and involuntary weight loss highlights its importance as an objective calculation method, particularly for dementia patients whose weight cannot be measured or known. It has been demonstrated that the CONUT score is related to mortality status regardless of age and years with dementia.
- 27 June 2025
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 10 (2) , 53-59
Open AccessThe relationship between Controlling Nutritional Status (CONUT) Score and Mortality in Elderly Dementia Patients Followed up in the Neurology Outpatient Clinic
Introduction: Dementia is a health issue that has become increasingly prevalent worldwide due to the rising life expectancy. It leads to dependency and eventually death. Patients over the age of 65 with dementia are at increased risk of malnutrition due to various problems with food intake. Maintaining adequate nutritional intake and nutritional status during the disease is crucial. It has been noted that loss of muscle mass, accompanied by loss of body weight and functional decline, is associated with an increased risk of morbidity and mortality in dementia patients. Guidelines emphasize that nutritional interventions should be an integral part of dementia treatment. However, the increase in dependency situations in the later stages of dementia makes it difficult to measure weight and calculate the weight change. Although different scales and indexes can be used to assess nutritional status, there is no gold standard. It has been shown that Controlling Nutritional Status (CONUT) scoring, which is created by scoring serum albumin, total cholesterol, and total lymphocytes, can be used in the early diagnosis and follow-up of malnutrition in different patient groups. Therefore, this study aims to evaluate the correlation between the CONUT score and the Mini Nutritional Assessment-Short Form (MNA-SF) in determining the malnutrition status of dementia patients aged 65 and over who are followed up in a neurology outpatient clinic and to examine the relationship between the CONUT score and mortality. Method: In the neurology outpatient clinic of a municipal day hospital, 113 patients aged 65 and over, out of 187 patients with a dementia diagnosis of at least one year, whose retrospective data were accessible, were included in the study. Their weight, height measurements, MNA-SF scores, serum albumin, total lymphocyte, and total cholesterol values were recorded from the system. The CONUT score was calculated based on biochemical data, and their three-month mortality statuses were checked from the e-Nabız system. Results: The average age of the patients was 80.9 (±7.48) years, with 63.7% being female. Most of the patients had Alzheimer's type dementia (76.9%), and 53.9% had a body mass index (BMI) of 5% in the last three months, while a negative correlation was found with BMI. Although there was no difference in the number of hospital admissions, those with malnutrition had a higher need for hospital admission (p=0.029). The mortality status of patients, regardless of age and years with dementia, was statistically significant with a CONUT score of ≥2 (0.63 (95% CI: 0.57-0.73)). Conclusion: A negative correlation was shown between the CONUT score (≥2 points), calculated with biochemical markers, and the MNA-SF, which is recommended for frequent use in the elderly for determining malnutrition. The CONUT score's association with BMI and involuntary weight loss highlights its importance as an objective calculation method, particularly for dementia patients whose weight cannot be measured or known. It has been demonstrated that the CONUT score is related to mortality status regardless of age and years with dementia.
- Open Access
- 1 March 2025
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 31 (1) , 53-61
A new method for the evaluation of cervical dystonia
Objectives: The study aimed to develop a measurement method that yielded objective data for the clinical assessment of cervical dystonia using a Kinect camera system. Patients and methods: This double-blind, parallel-group method development study included 22 patients with cervical dystonia (3 males, 19 females; mean age: 47 years; range, 34 to 60 years) and 20 healthy individuals (13 females, 7 males; mean age: 32 years; age range, 22 to 65). Using cameras and a computer software, the head-neck postures of 40 healthy participants were recorded in the virtual environment. Using the device, 22 patients with cervical dystonia were examined both at rest and while moving with different parts of the body. Two different experts evaluated and scored the cases using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) and the Tsui scale. Results: A three-way comparison revealed interclass correlations between the coefficients of 0.799 (79.9%) and 0.784 (78.4%) for at rest and with movement, respectively. The two-way comparison of the experts revealed correlation coefficients of 0.717 (71.7%) and 0.692 (69.2%) for at rest and with movement, respectively. A three-way comparison of the device and Expert 1 and Expert 2 TWSTRS scores revealed interrater agreement values of 0.6 and 0.8 (good) and 0.6 and 0.8 (good) while at rest and with movement, respectively. A three-way comparison of the device and Expert 1 and Expert 2 Tsui scores revealed interrater agreement values of 0.6 and 0.8 (good) and 0.4 and 0.6 (moderate) while at rest and with movement, respectively. Conclusion: The newly developed system was a sensitive tool for use in the kinematic evaluation of patients with cervical dystonia and could prove beneficial in diagnosis and treatment follow-up.
- 1 March 2025
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 31 (1) , 53-61
Open AccessA new method for the evaluation of cervical dystonia
Objectives: The study aimed to develop a measurement method that yielded objective data for the clinical assessment of cervical dystonia using a Kinect camera system. Patients and methods: This double-blind, parallel-group method development study included 22 patients with cervical dystonia (3 males, 19 females; mean age: 47 years; range, 34 to 60 years) and 20 healthy individuals (13 females, 7 males; mean age: 32 years; age range, 22 to 65). Using cameras and a computer software, the head-neck postures of 40 healthy participants were recorded in the virtual environment. Using the device, 22 patients with cervical dystonia were examined both at rest and while moving with different parts of the body. Two different experts evaluated and scored the cases using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) and the Tsui scale. Results: A three-way comparison revealed interclass correlations between the coefficients of 0.799 (79.9%) and 0.784 (78.4%) for at rest and with movement, respectively. The two-way comparison of the experts revealed correlation coefficients of 0.717 (71.7%) and 0.692 (69.2%) for at rest and with movement, respectively. A three-way comparison of the device and Expert 1 and Expert 2 TWSTRS scores revealed interrater agreement values of 0.6 and 0.8 (good) and 0.6 and 0.8 (good) while at rest and with movement, respectively. A three-way comparison of the device and Expert 1 and Expert 2 Tsui scores revealed interrater agreement values of 0.6 and 0.8 (good) and 0.4 and 0.6 (moderate) while at rest and with movement, respectively. Conclusion: The newly developed system was a sensitive tool for use in the kinematic evaluation of patients with cervical dystonia and could prove beneficial in diagnosis and treatment follow-up.